Alder BioPharmaceuticals Reports Third Quarter 2015 Financial and Operating Results

Go back to Alder BioPharmaceuticals Reports Third Quarter 2015 Financial and Operating Results

Alder BioPharma (ALDR) Misses Q3 EPS by 11c

November 5, 2015 4:46 PM EST

Alder BioPharma (NASDAQ: ALDR) reported Q3 EPS of ($0.62), $0.11 worse than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Alder BioPharma (ALDR) click here.

... More